Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 4 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Recs

0
Player Avatar Omen1618 (< 20) Submitted: 10/21/2011 10:57:19 AM : Outperform Start Price: $31.50 RDY Score: -10.72

This company makes generic pharmaceuticals, ton of pharma patents coming due in the near future which provides DRL with a big upside.

Featured Broker Partners


Advertisement